1-4 of 4
Anna Falanga
Close
Sort by
Journal Articles

Evidence-Based Minireview: Are DOACs an alternative to vitamin K antagonists for treatment of venous thromboembolism in patients with MPN?

Francesca Schieppati, Anna Falanga
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2021) 2021 (1): 448–452.
https://doi.org/10.1182/hematology.2021000318
Published: 2021
Journal Articles

MPN and thrombosis was hard enough . . . now there's COVID-19 thrombosis too

Anna Falanga
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2021) 2021 (1): 710–717.
https://doi.org/10.1182/hematology.2021000315
Published: 2021
Journal Articles

Thrombotic disease in the myeloproliferative neoplasms

Anna Falanga, Marina Marchetti
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 571–581.
https://doi.org/10.1182/asheducation.V2012.1.571.3798557
Published: 2012
Journal Articles

Management of Thrombohemorrhagic Syndromes (THS) in Hematologic Malignancies

Anna Falanga, Frederick R. Rickles
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2007) 2007 (1): 165–171.
https://doi.org/10.1182/asheducation-2007.1.165
Published: 2007